From: Albumin redox state of maintenance haemodialysis patients is positively altered after treatment
Characteristic | All n = 58 | Polysulfone low flux n = 32 | Polysulfone high flux n = 16 |
---|---|---|---|
Demographic data | |||
Age [years], median (range) | 68 (27–89) | 70 (37–84) | 64 (27–89) |
Men, n [%] | 34 (59) | 18 (56) | 11 (69) |
Women, n [%] | 24 (41) | 14 (44) | 5 (31) |
Weight before treatment [kg], median (range) | 83 (58–145) | 84 (59–145) | 79 (58–140) |
BUN before treatment [mg/dl], median (IQR) | 60.8 (53.4–68.7) | 63.7 (52.5–69.4) | 58.8 (52.3–65.6) |
Ultrafiltration [L], median (range) | 2.4 (+ 1.1 - -4.5) | 2.3 (+ 1.1- -4.3) | 1.8 (0.8–3.3) |
Renal disease, n [%] | |||
Nephrosclerosis due to hypertension | 38 (66) | 26 (81) | 7 (44) |
Diabetic nephropathy | 18 (31) | 14 (44) | 3 (19) |
Autoimmune diseases (IgA nephropathy, SLE, AAV) | 15 (26) | 11 (34) | 1 (6) |
ADPKD | 3 (5) | 0 | 1 (6) |
Unknown | 4 (7) | 0 | 4 (25) |
Other | 16 (27) | 7 (22) | 3 (19) |